Do you support this bill?

Senate Bill S8316

2019-2020 Legislative Session

Relates to determining whether the state can claim federal financial participation for coverage of and payment for certain prescription digital therapeutics

download bill text pdf

Sponsored By

Archive: Last Bill Status - In Senate Committee Health Committee

Please enter your contact information

Home address is used to determine the senate district in which you reside. Your support or opposition to this bill is then shared immediately with the senator who represents you.

Optional services from the NY State Senate:

Create an account. An account allows you to officially support or oppose key legislation, sign petitions with a single click, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.

Include a custom message for your Senator? (Optional)

Enter a message to your senator. Many New Yorkers use this to share the reasoning behind their support or opposition to the bill. Others might share a personal anecdote about how the bill would affect them or people they care about.

Actions

2019-S8316 (ACTIVE) - Details

See Assembly Version of this Bill:
A10385
Current Committee:
Senate Health
Law Section:
Medical Assistance
Versions Introduced in 2021-2022 Legislative Session:
S559, A3642

2019-S8316 (ACTIVE) - Summary

Directs the department of health to request guidance from the Centers for Medicare and Medicaid Services to determine whether the state can claim federal financial participation for coverage of and payment for certain prescription digital therapeutics.

2019-S8316 (ACTIVE) - Sponsor Memo

2019-S8316 (ACTIVE) - Bill Text download pdf 

                            
 
                     S T A T E   O F   N E W   Y O R K
 ________________________________________________________________________
 
                                   8316
 
                             I N  S E N A T E
 
                               May 11, 2020
                                ___________
 
 Introduced  by Sen. HARCKHAM -- read twice and ordered printed, and when
   printed to be committed to the Committee on Health
 
 AN ACT in relation to determining whether the state  can  claim  federal
   financial  participation  for  coverage  of  and  payment  for certain
   prescription digital therapeutics
 
   THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND  ASSEM-
 BLY, DO ENACT AS FOLLOWS:
 
   Section  1. Legislative finding and declaration. New Yorkers in recov-
 ery for substance and opioid use disorders and in treatment  for  mental
 health  conditions  are  losing  access to in-person treatment under the
 state's "stay at home" and social distancing orders as part of coronavi-
 rus pandemic mitigation efforts. In recent news  reports,  experts  warn
 that  the  coronavirus  pandemic may be "a national relapse trigger" for
 individuals in treatment for alcohol, cocaine, methamphetamine, marijua-
 na, and heroin addiction.  Prescription Digital Therapeutics (PDTs)  are
 new,  software-based  disease  treatments  designed  to  directly  treat
 disease, tested for safety and efficacy in randomized  clinical  trials,
 evaluated  by  the  FDA,  and  prescribed by healthcare providers. These
 therapies are designed and tested  much  like  traditional  prescription
 drugs  with  one distinction: rather than swallowing a pill or taking an
 injection, patients are treated  with  software.  Certain  PDTs  provide
 clinicians  and patients with evidence-based remote treatment modalities
 to treat substance and opioid use disorders, mental  health,  and  other
 diseases  and  conditions.  However, there is no clear statutory benefit
 category to allow Medicaid coverage for PDTs. In light of the promise of
 PDTs for the treatment of patients with substance  use  and  opioid  use
 disorders  during  the  coronavirus  pandemic,  this  legislation  would
 require that the New York state department of health seek guidance  from
 the  Centers  for  Medicare and Medicaid Services relative to a coverage
 and reimbursement pathway for PDTs, in order  to  accelerate  access  to
 such therapies for enrollees.
   §  2.  No  later than 30 days from the effective date of this section,
 the New York state department of health shall request guidance from  the
 Centers  for  Medicare  and  Medicaid  Services to determine whether the
 
  EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets

Comments

Open Legislation is a forum for New York State legislation. All comments are subject to review and community moderation is encouraged.

Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity, hate or toxic speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Attempts to intimidate and silence contributors or deliberately deceive the public, including excessive or extraneous posting/posts, or coordinated activity, are prohibited and may result in the temporary or permanent banning of the user. Comment moderation is generally performed Monday through Friday. By contributing or voting you agree to the Terms of Participation and verify you are over 13.

Create an account. An account allows you to sign petitions with a single click, officially support or oppose key legislation, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.